MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinipace, a digital clinical research organization, announced today that Inspire Pharmaceuticals, Inc. has selected the company to manage and deploy two phase II studies for the ophthalmic prescription medicine, AzaSite®.
